Harvard researchers have discovered a piece of the puzzle that may help unlock new experimental treatments for amyotrophic lateral sclerosis, often referred to as Lou Gehrig’s disease. Oleg Butovsky, HMS instructor in neurology and Howard Weiner, the Robert L. Kroc Professor of Neurology, both of Brigham and Women’s Hospital, led the study.
